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Target skin cells induce the neuropeptide calcitonin gene-related peptide (CGRP) in naı¨ve embryonic dorsal root ganglion
(DRG) neurons in vitro, but the molecular basis of that induction is not known. Recombinant activin or bone
orphogenetic proteins (BMPs) dramatically increase the number of sensory neurons with CGRP and substance P in vitro
X. Ai et al., 1999, Mol. Cell. Neurosci. 14, 506–518). These experiments were designed to test if activin or BMPs accounted
for the CGRP-inductive activity by skin cells. To identify factors from skin that induce CGRP, we developed a bioassay in
which embryonic DRG neurons isolated before peripheral target contact in vivo are challenged in vitro with specific factors.
Conditioned medium from an embryonic rat skin cell line induced neuronal CGRP expression, and induction was blocked
by follistatin, implicating transforming growth factor b family members. Immunoblot analysis revealed that the skin cell
ine medium contained several activin and bone morphogenetic protein moieties. Antibody specific to activin neutralized
ost of the CGRP-inductive activity in skin conditioned medium. These data indicate that the CGRP-inductive action of
kin cells involves activin and establish activin as a candidate regulator of this sensory neuropeptide phenotype during
evelopment. © 2000 Academic Press
Key Words: dorsal root ganglion; sensory neuron; activin; transforming growth factor b; activin; bone morphogenetic
protein; calcitonin gene-related peptide; target-derived factor; skin.1INTRODUCTION
Adult dorsal root ganglion (DRG) sensory neurons differ
in neurochemical features, size, and peripheral and central
connections. Neuropeptides, including calcitonin gene-
related peptide (CGRP), are generally expressed in small
neurons that innervate skin and viscera, whereas abundant
phosphorylated neurofilament expression is in large neu-
rons that innervate muscle and joint (Lee et al., 1985;
Molander et al., 1987; O’Brien et al., 1989; McCarthy and
Lawson, 1990; Scott, 1992). CGRP is a potent vasodilator
involved in neurogenic inflammation as well as pain sen-
sation (Brain et al., 1985; Holzer, 1988), and it is important
to learn how CGRP-containing neurons are generated dur-
ing development and functionally matched with targets.
The time that neuropeptides appear suggests that periph-
eral target tissues play a role in specifying CGRP-
containing neurons in the DRG. Cutaneous afferents appear
in rat proximal hindlimb on embryonic days 14–15 (E14–
15) and in skin of toes at E16–17 (Mirnics and Koerber,
1995). No CGRP mRNA or protein is detectable in E14.5 rat
0012-1606/00 $35.00
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All rights of reproduction in any form reserved.lumbar DRG (Hall et al., 1997), but neuropeptides appear
when peripheral connections are functional (E18–19;
Kessler and Black, 1981; Senba et al., 1982; Narayanan et
al., 1971; Saito, 1979; Kudo and Yamada, 1985; Marti et al.,
1987; Hall et al., 1997). Further, embryonic avian sensory
ganglia cocultured with target muscle, skin, brain, or spinal
cord alter their neuropeptide expression (Barakat-Walter et
al., 1991; Duc et al., 1991). Likewise, embryonic rat DRG
neurons initially lack CGRP but express the neuropeptide
after stimulation in vitro (Hall et al., 1997; Ai and Hall,
1998) and coculture with skin increases CGRP-IR neurons
(Hall et al., 1997). Thus, target tissues can regulate CGRP in
developing sensory neurons, but the factors responsible for
the changes are not known.
Skin and gut targets for CGRP sensory neurons express
transforming growth factor b (TGFb) family members in-
cluding activin (Roberts and Barth, 1994) and bone morpho-
genetic proteins (BMPs) (Lyons et al., 1990; Jones et al.,
991; Winnier et al., 1995; Wall et al., 1993). These proteins
are important during morphogenesis (see Kingsley, 1994;
Hogan, 1996; Mehler et al., 1997) and in nervous system
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264 Hall, Dinsio, and Cappuzzellodevelopment (Liem et al., 1995, 1997; Varley et al., 1995,
1998; Shah et al., 1996; Reissmann et al., 1996; Graham et
l., 1994; Gross et al., 1996; Darland et al., 1998). TGFb
family members include the activin subfamily, the dpp
subfamily (BMP2, BMP4), and the 60A subfamily (BMPs
5–8). In the peripheral nervous system, activin increases
neuropeptide expression in avian ciliary ganglia (Coulombe
et al., 1993; Nishi, 1994; Darland, et al., 1998). BMPs are
also implicated in avian adrenergic differentiation (Reiss-
mann et al., 1996; Varley et al., 1995; Schneider et al.,
1999), neural crest stem cell differentiation (Shah et al.,
1996), neuropeptide regulation in sympathetic ganglia
(Fann and Patterson, 1994), and dendritic growth (Lein et
al., 1995). The role of activin and BMPs in sensory neu-
ropeptide development is not known.
Target skin cells induce CGRP in naı¨ve embryonic sen-
sory neurons (Hall et al., 1997), and recombinant activin
nd BMPs induce the pain-sensing neuronal phenotype that
ncludes CGRP in vitro (Ai et al., 1999). From these and
ther data, we proposed that activin or BMPs in skin
nduced the pain-sensing phenotype only in neurons that
ontacted these targets. To test this notion, a serum-free
ulture system was used to characterize factors made by a
kin cell line that induce de novo CGRP expression by
mbryonic DRG neurons. In some cases, antagonists such
s follistatin or specific neutralizing antibodies were used
o test the action of the ligands. Here we show that skin
ells secrete soluble factors that induce CGRP in embry-
nic sensory neurons and that activin is a strong molecular
andidate for that inducer.
MATERIALS AND METHODS
Cell Culture
Embryonic 14.5 dorsal root ganglia from timed pregnant
Sprague–Dawley rats (Zivic Miller, Zelienople, PA) were dissoci-
ated as described previously (Hall et al., 1997). Four thousand cells
er 0.32 cm2 were grown in 96-well plates and maintained in
defined neurobasal medium (Gibco) with B-27 medium supplement
(Gibco), 3 mM glutamine, and 25 ng/ml nerve growth factor (NGF;
Austral). Half the medium was replaced every other day.
Conditioned Medium
To test if target cells can produce soluble factors that induce
CGRP expression, control 3T3 cells or rat embryonic skin cells
(CRL 1213; American Type Culture Collection) were cultured in
DMEM with 10% FBS until confluent. The CRL 1213 cell line was
isolated as a skin biopsy from an E18 Sprague–Dawley rat fetus.
Cells were then washed well and maintained in defined keratino-
cyte serum-free medium (Gibco). After 2 days, conditioned me-
dium (CM) was collected, spun to remove debris, and frozen before
use. No difference was obtained with frozen or fresh medium.
Neuronal cultures were fed a mix of CM with equal volume of fresh
neurobasal medium including the growth supplements above.
In some cases, spin columns were used to separate fractions of
CM by molecular size in separate samples. Three- or 30-kDa cut-off
concentrators (Amicon, Fisher) were used to separate CM and each
Copyright © 2000 by Academic Press. All rightfraction was restored to starting volume with keratinocyte medium
and then tested on DRG cultures. Half this growth medium was
changed every 2 days.
Immunocytochemistry
Embryonic DRG cultures were grown for 8 days until cells were
aged approximately equivalent to the day of birth and when CGRP
expression stabilized (see Hall et al., 1997; Ai et al., 1999). Cells
ere fixed in 4% paraformaldehyde/0.1 M phosphate buffer, pH
.4, for 30 min at room temperature. After being rinsed, cells were
ermeabilized and nonspecific sites were blocked in dilution buffer
hat contained 0.4% Triton X-100/PBS, 20% goat serum, and
.01% sodium azide for 2 h at room temperature. Primary CGRP
ntiserum (1:8000; Sigma) in dilution buffer was applied at 4°C
vernight. After rinsing, biotinylated anti-rabbit IgG was applied
or 2 h at room temperature. CGRP expression was assayed using
he ABC kit (Vector) with a diaminobenzidine chromogen. The
pecificity of the CGRP antiserum was determined by blocking
ith CGRP (25 mg/ml; Peninsula) at 4°C overnight followed by the
sual staining process. In the presence of blocking peptide, no
pecific signal was detected.
Electrophoresis and Immunoblot
Proteins were separated by SDS–PAGE (Laemmli, 1970) using
8 3 6-cm gels of 15% acrylamide. After electrophoresis, proteins
ere transferred to PVDF membrane and detected by immunoblot-
ing techniques. Nonspecific sites were blocked by incubation with
ovine serum albumen/Tween 20/Tris-buffered saline for 2 h at
oom temperature. Filters were then incubated with primary anti-
ody in Tween/TBS overnight at 4°C. After being washed with
ween/TBS, membranes were incubated with peroxidase-coupled
econd antibody (1:2000; Chemicon) for 2 h at room temperature.
embranes were washed again and antigens visualized by en-
anced chemiluminescence (Supersignal; Pierce). Primary antibod-
es utilized in the study included mouse monoclonal antibodies to
MP2, BMPs 2 and 4, BMP6 (obtained from Genetics Institute),
MP4 (R&D Systems, neutralizing), and polyclonal goat anti-
ctivin A (R&D Systems, neutralizing).
Bioassays
To test the role of specific TGFb family members in skin
onditioned medium, neutralizing antibody was mixed with
erum-free skin conditioned medium for 1 h and the mixture used
o feed embryonic DRG cultures. Blocking antibodies to activin
R&D Systems) or BMP4 (R&D Systems) were used. In some cases,
nti-BMP6 (Genetics Institute) was assayed at 1–10 mg/ml concen-
ration, but significant neuronal death was observed. Recombinant
uman follistatin (obtained from National Hormone and Pituitary
rogram, NIDDK, with thanks to Dr. A. Parlow) was added to skin
M to test the role of TGFb molecules.
In each case, each variable was added to triplicate wells in a
single experiment, and at least three independent experiments
were performed. At least 200 neurons per well were evaluated for
CGRP reactivity, and the proportions of CGRP-immunoreactive
neurons under particular conditions were compared by unpaired t
test with Statview statistical analysis package with two-way
ANOVA.
s of reproduction in any form reserved.
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265Skin Induction of Sensory NeuropeptidesRESULTS
Several observations led to the hypothesis that skin cell
line conditioned medium induced the pain-sensing neuro-
nal phenotype in embryonic DRG neurons via a TGFb
family member. Coculture with the skin cells, but not
primary hindlimb muscle or control 3T3 cells, increased
the proportion of CGRP-containing neurons in embryonic
DRG cultures (Hall et al., 1997). Further, recombinant
activin or BMPs have a profound effect on CGRP and
substance P expression in developing sensory neurons (Ai et
al., 1999). Skin cells in vivo express activin and BMP
mRNA during embryogenesis (Roberts and Barth, 1994; Ai
et al., 1999). The experiments in this study were designed to
test whether these molecules accounted for the CGRP
inductive activity by the skin cells.
Neuronal CGRP Expression Induced by Skin
Conditioned Medium Was Inhibited by Follistatin
We have shown that in defined medium, few embryonic
sensory neurons express CGRP unless specific stimuli are
applied (Hall et al., 1997; Ai et al., 1998, 1999). Coculture
with a skin cell line significantly increased the proportion
of CGRP-IR neurons in DRG cultures (Hall et al., 1997). To
test if CGRP induction by skin involved soluble factors,
skin cells were allowed to condition defined keratinocyte
medium (skin CM), which was applied to DRG cultures.
Skin CM induced over a third of neurons to be CGRP-
immunoreactive (Fig. 1) while few developed the neuropep-
tide in control medium. No difference was seen in neuronal
survival in either medium (over 80% of neurons survived 8
days, P 5 0.26). These data suggest that the CGRP-
inductive factors from skin cells are soluble.
To begin to characterize regulatory factors that stimulate
CGRP expression in DRG neurons, follistatin, an inhibitor
of multiple TGFb family members was added chronically to
eurons in skin cell conditioned medium (Fig. 1). Follistatin
locks activin and several BMPs (Nakamura et al., 1990;
ainsod et al., 1997; Iemura et al., 1998). Cells were fed
very other day and assayed for CGRP immunoreactivity at
ay 8 of culture. Follistatin had no effect on neuronal
urvival at any concentration tested (80% of neurons
ounted on day 1 survived 8 days). The addition of follista-
in at 1–5 mg/ml to skin CM decreased CGRP expression to
control levels (Fig. 1). These data suggest that the soluble
factors secreted from the skin cell line that induce neuronal
CGRP expression were TGFb family members.
TGFb Family Members in Skin Cell Line
onditioned Medium
Secreted factors in the skin cell line conditioned medium
were concentrated and analyzed by Western immunoblot
with antibodies specific for TGFb family members (Fig. 2).
To confirm the specificity of the reagents and the expected
molecular mass of the ligands, recombinant activin and
BMP controls were included in the assays. The members of K
Copyright © 2000 by Academic Press. All rightthe TGFb family are initially synthesized as a large precur-
or (about 110 kDa) processed to a smaller form (about 55
Da) and then secreted from cells as homodimers (see
FIG. 1. Skin cell line conditioned medium induces CGRP, and
activity can be blocked with follistatin. Skin cell line conditioned
keratinocyte medium was added 1:1 with neurobasal medium and
NGF to embryonic DRG cultures, and CGRP immunoreactivity
assayed after 8 days in vitro. (A) Skin conditioned medium induced
robust CGRP immunoreactivity in many neurons and their pro-
cesses. (B) Few neurons expressed the neuropeptide in control
keratinocyte/neurobasal medium. (C) The addition of 1–5 mg/ml
follistatin blocked CGRP induction by skin conditioned medium,
so few neurons were CGRP-immunoreactive. (D) Quantitation of
data. Data represent means and standard errors of the mean. Each
variable was tested in triplicate wells in each experiment and three
independent experiments were analyzed for statistical data by
Statview analysis and two-way ANOVA. The effects of follistatin
addition were the same at 1 and 5 mg/ml, P 5 0.93, and were the
ame as control medium, P . 0.2.ingsley, 1994, for review; Bilezikjian et al., 1993; Mason et
s of reproduction in any form reserved.
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266 Hall, Dinsio, and Cappuzzelloal., 1996). Thus, monomers of activin and BMPs have
expected molecular weights of approximately 14 and 18
kDa, respectively, on reducing gels. Each of the antibodies
demonstrated strong selectivity only for individual ligands,
as expected, suggesting that they could be used to detect
particular ligands in skin cell conditioned medium. Skin
cell line conditioned medium contained an approximately
14-kDa band that reacted with activin antibody, suggesting
that fully processed, monomer-sized activin was present in
the secreted conditioned medium. In addition, higher mo-
lecular weight material reactive with activin antibody was
also present and may represent precursor forms of activin.
When skin conditioned medium was assayed for BMPs,
only BMP6-immunoreactive material was present at the
expected molecular weights for the ligand monomer. How-
ever, higher molecular weight material, perhaps reflecting
precursor forms, was reactive with BMP2/4- and BMP2-
specific antibodies. This analysis indicates that, along with
additional higher molecular weight immunoreactive mate-
rial, monomer-sized activin and BMP6 were present in skin
conditioned medium.
To begin to characterize the molecules responsible for
CGRP-inducing activity in skin cell line conditioned me-
dium, an initial fractionation was performed. While mono-
mer forms of the TGFb family have molecular weights
round 15 kDa on denaturing gels, they actually exist under
FIG. 2. Skin cell line conditioned medium contains multiple
GFb ligands. To learn which ligands were present, fivefold
concentrated skin cell line conditioned medium (scm) or 10 ng
recombinant ligand (activin, A; BMP2, 4, or 6) standards were
separated by electrophoresis and immunoblotted with antibody to
BMP6, BMP2/4, activin (anti-Act), or BMP2. As expected, antibod-
ies reacted only with selected recombinant ligands, indicating their
specificity. Skin cell line conditioned medium contained BMP6-
and activin-immunoreactive material at the molecular weights
expected for monomer ligand. Only higher molecular weight ma-
terial in skin conditioned medium was reactive with BMP2/4- and
BMP2-specific antibodies. Thus, in addition to higher molecular
weight immunoreactive material, monomer-sized immunoreactive
activin and BMP6 were present in skin conditioned medium.ative conditions as dimers of twice that size. Skin condi-
Copyright © 2000 by Academic Press. All rightioned medium was separated with a 30-kDa molecular
eight cut-off filter, and each fraction was reconstituted to
he original volume with keratinocyte defined medium.
he high- and low-molecular-weight fractions were then
pplied to DRG neurons. CGRP-inductive activity was
ntirely present in the higher molecular weight material
Fig. 3A). These data are consistent with a dimeric TGFb
family member or high-molecular-weight precursor being
responsible for CGRP induction. In contrast, the size frac-
tionation results rule out smaller molecules such as cyto-
kines for the inductive action. These fractions were then
analyzed for the presence of activin. Both unfractionated
skin cell line conditioned medium and the high-molecular-
weight fraction contained activin material at expected Mr
for the ligand (Fig. 3B). The low-molecular-weight fraction
had no detectable activin reactivity. Size fractionation
identified the action of a relatively large molecule in skin
conditioned medium as responsible for CGRP induction.
FIG. 3. CGRP-inducing activity is in the $30-kDa fraction that
contains activin. Skin cell conditioned medium (SCM) was concen-
trated with a 3-kDa filter, and higher and lower molecular weight
moieties were separated with a 30-kDa cut-off filter. The resulting
fractions were tested for CGRP-inducing activity and separated by
electrophoresis and immunoblotted with an antibody against ac-
tivin. (A) The inducing activity of the .30-kDa fraction was
identical to unfractionated skin cell conditioned medium, while
the ,30-kDa fraction had no inducing activity and was the same as
neurobasal defined medium alone (P , 0.001). (B) Activin immu-
noblot against recombinant activin and skin cell conditioned
medium. Recombinant activin appeared at the expected monomer
size (14 kDa) and as a dimer of higher molecular weight (approxi-
mately 30 kDa). Native skin cell line conditioned medium con-
tained immunoreactive material at 14 kDa under reducing condi-
tions, consistent with the presence of activin. The fraction
containing material .30 kDa, but not that ,30 kDa, contained
immunoreactive activin. It is important to recognize that activin
ligand exists as a dimer under nonreducing conditions. The blot
also includes a lane that contains buffer (2).
s of reproduction in any form reserved.
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267Skin Induction of Sensory NeuropeptidesAntibody Neutralization of TGFb Family Members
n Skin Conditioned Medium
Antibodies that block function of specific ligands were
used to identify active ligands in conditioned medium. We
had shown in earlier results that activin and BMP6 forms
consistent with active ligand were present in skin condi-
tioned medium, while BMP2 and BMP4 were present only
at molecular weights that correspond with potential precur-
sor forms. Anti-activin (R&D systems) or anti-BMP4 (R&D
Systems) antibody was added to skin cell line conditioned
medium and subsequent CGRP induction in embryonic
DRG assayed. As shown above, immunoblot analysis indi-
cates that, as expected, only the activin standard was
detected with the anti-activin reagent (Fig. 2). Antibody to
activin at 1 mg/ml blocked some CGRP induction, and the
ddition of 5 mg/ml anti-activin blocked 77% of the CGRP
nduction by skin CM (Fig. 4). For comparison, follistatin
locks over 90% of the induction by skin CM (see Fig. 1). In
ontrast, antibody to BMP4 at 1 and 5 mg/ml did not block
ability of skin cell line conditioned medium to induce
CGRP. In control studies (Fig. 5), the BMP4 antibody at
similar concentrations effectively blocked BMP4-mediated
increases in CGRP, an observation that confirms the neu-
tralizing activity of this reagent. These data demonstrate
that the majority of the CGRP-inductive activity in skin
FIG. 4. Anti-activin antibody blocks induction by skin cell line
conditioned medium. The ability of neutralizing antibody to block
skin cell conditioned medium activity was tested. The proportion
of CGRP-immunoreactive neurons in basal defined medium was
subtracted from that induced by skin cell line conditioned me-
dium, and the resulting value was normalized to 100%. To learn if
specific molecules inhibited CGRP induction by skin conditioned
medium, antibody to activin or BMP4 was added. The addition of 1
mg/ml (aAct1) or 5 mg/ml anti-activin (aAct5) antibody blocked up
to 77% of the skin CM-inductive activity. The addition of 5 mg/ml
nti-BMP4, however, had no effect. Neuronal survival was similar
n all cases (80%). The mean proportion of CGRP-IR neurons was
erived from three experiments each in triplicate, with the ob-
erved percentages of CGRP-immunoreactive neurons as follows:
eratinocyte/NB control 7.3% 6 0.9, skin conditioned medium
32.9 6 1.5, 1 mg/ml activin 26.2 6 1.5, 5 mg/ml activin 15.767 6 1.9,
mg/ml BMP4 31.2 6 1.8 SEM.cell line conditioned medium is due to activin.
Copyright © 2000 by Academic Press. All rightDISCUSSION
This study focuses on the development of sensory neu-
rons containing the neuropeptide calcitonin gene-related
peptide that predominantly contact skin, blood vessel, and
gut peripheral target tissues in vivo. We hypothesize that
elected target-derived TGFb family members induce
CGRP in the DRG neurons that contact them. A model for
one such target tissue, a skin cell line originally isolated
from embryonic day 18 rat skin biopsy, was used to identify
active ligands in a robust bioassay for de novo CGRP
induction in DRG neurons (Hall et al., 1997; Ai et al., 1998,
1999). The inductive factors from skin were shown to be
soluble, of 30 kDa or greater Mr under native conditions,
and fully inhibited by the addition of follistatin, observa-
tions that implicate the action of dimeric TGFb family
members. Indeed, skin conditioned medium was shown to
contain several TGFb family members, and specific neu-
ralizing antibody to activin blocked CGRP induction by
kin conditioned medium. These data in combination iden-
ify activin as the candidate ligand for the action of skin
arget tissue on developing sensory neurons.
The timing of neuropeptide development in vivo is con-
istent with a role for peripheral target contact in CGRP
nd substance P expression. Cutaneous afferents begin to
nter the rat proximal hindlimb on E14.5–E15 and skin of
he distal toes at E16–E17 (Mirnics and Koerber, 1995;
eynolds et al., 1991). Neuropeptides appear around the
time afferents respond to peripheral stimulation, several
days later (about E18; Kessler and Black, 1981; Fitzgerald,
FIG. 5. BMP4 neutralizing activity blocks BMP4-mediated in-
creases in CGRP. In control studies, embryonic DRG grown for 8
days with 10 ng/ml BMP4 included numerous CGRP-
immunoreactive neurons, as expected. The addition of 5 mg/ml
anti-BMP4 neutralizing antibody blocked the ability of BMP4 to
induce CGRP in these cultures.
s of reproduction in any form reserved.
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268 Hall, Dinsio, and Cappuzzello1986, 1987, 1991; Kudo and Yamada, 1985; Senba et al.,
1982). Likewise, embryonic skin is differentiating during
this time (Kopan and Fuchs, 1989). In contrast, sensory
afferents from lumbar regions reach the spinal cord at E12
but do not penetrate the gray matter until E15 (Reynolds et
al., 1991), and the formation of central connections is not
temporally correlated with peptide development.
TGFb family members have been implicated in sympa-
hetic and parasympathetic neuron differentiation. For ex-
mple, BMP4 and BMP7 induce avian adrenergic differen-
iation and are expressed in dorsal aorta adjacent to
ympathetic ganglia (Reissmann et al., 1996; Varley et al.,
995). BMP2, BMP6, and BMP7 regulate dendritic growth
nd the expression of microtubule-associated protein-2 in
at sympathetic neurons (Lein et al., 1995). Moreover,
MP2 and BMP6 affect the expression of neurotransmitters
nd neuropeptides in rat neonatal sympathetic neurons
Fann and Patterson, 1993, 1994). Activin acts as target-
erived factor to increase the expression of the neuropep-
ide somatostatin in avian parasympathetic ciliary ganglion
Coulombe et al., 1993; Nishi, 1994; Darland et al., 1998).
e have shown that recombinant activin and BMPs 2, 4,
nd 6, can induce CGRP in embryonic sensory neurons in
itro (Ai et al., 1999).
The present study identifies the molecular moieties ac-
ive in skin cells that alter sensory neuron phenotype. The
oluble activity from the embryonic skin cell line was
nhibited by follistatin, suggesting that the active factors
rom skin were members of the TGFb ligand family. West-
ern immunoblot data identified immunoreactive material
at molecular weights consistent with activin and BMP6
ligands and additional, higher molecular weight moieties.
We and others have shown that native embryonic rodent
skin expresses mRNA specific for BMPs 2, 4, and 6 and
activin during the period of sensory target contact (Blessing
et al., 1996; Lyons et al., 1990; Wall et al., 1993; Roberts and
Barth, 1994; Roberts et al., 1991; Ai et al., 1999), although
the location and activity of these ligands are not clear. We
demonstrated BMP mRNA in embryonic rat skin and gut
(Ai et al., 1999), and the present study provides some
information about the proteinaceous moieties present.
While not precise in localization, these studies suggest that
one or more TGFb family ligand mRNAs are expressed by
eripheral targets at relevant embryonic stages to regulate
xpression of CGRP. Follistatin binds activin and, less
ffectively, BMPs 4 and 7 (Nakamura et al., 1990), although
ts ability to bind to the higher molecular weight BMP-
mmunoreactive material we found in skin is not known.
TGFb ligand family members have direct effects on
ensory neurons. Addition of BMPs to embryonic DRG
ultures in which nonneuronal cells were eliminated re-
ulted in concentration-dependent inductive effects on
GRP expression similar to those in complete cultures
ontaining neurons and nonneuronal cells (Ai et al., 1999).
urther, brief treatment of DRG cultures with ligand re-
ulted in rapid Smad transcription factor translocation into
euronal nuclei, indicating that effects of ligand occurred
Copyright © 2000 by Academic Press. All rightirectly on neurons (Ai et al., 1999). Similarly, DRGs
xpress a variety of TGFb ligand family receptors during
arly development (Dewulf et al., 1995; Bengtsson et al.,
995; So¨derstro¨m et al., 1996; Roberts and Barth, 1994;
eijen et al., 1994). The embryonic rat DRG contains
RNA for BMP type IA receptor, BMP type II receptor, and
ctivin receptor types I, II, and IIB, but not BMP receptor
ype IB (Ai et al., 1999). Thus, neurons have both receptor
ubunits and signaling mechanisms that facilitate re-
ponses to TGFb ligands.
The ability of anti-activin to block most inducing activity
ven in the presence of BMP6 ligand indicates one of several
ossibilities. Although it was theoretically possible that the
ntibodies neutralized more than one ligand, Western im-
unoblot with recombinant ligands suggested that each
ntibody reagent was quite specific. Alternatively, activin
ay be more plentiful in skin than BMP6. This possibility
oes not seem very likely as each ligand was readily
etectable in the same sample by Western immunoblot.
ne interesting possibility is that activin may be the
ominant ligand because BMP6 activity in skin is very
ocally blocked by an endogenous inhibitor. The BMP
amily can be blocked by a variety of inhibitors, such as
oggin and chordin (Hirsinger et al., 1997; Marcelle et al.,
997; Smith and Harland, 1992; Piccolo et al., 1996; Zim-
erman et al., 1996), follistatin (Nakamura et al., 1990;
ainsod et al., 1997; Iemura et al., 1998), or gremlin (Merino
t al., 1999). Noggin is expressed in developing rodent
artilage and chondrocytes (Pathi et al., 1999) as well as
eural tube (McMahon et al., 1998). While less is known
bout gremlin, the mRNA has been detected in avian
uscles and feather buds (Merino et al., 1999). Follistatin is
xpressed in regions associated with tendon formation in
eveloping chick limb (D’Souza and Patel, 1999). The
areful analysis of both TGFb family ligand and receptor
expression in skin during the period of sensory neuron
contact with target remains an important future objective.
The identification of ligands present in skin cells that
induce CGRP in DRG neurons provides strong support for
target-mediated regulation of the sensory CGRP phenotype.
Further, identification of these active molecules using this
bioassay facilitates analysis of this mechanism in other
systems. The present study documents that a skin cell line
contains activin and BMP6 and demonstrates using func-
tional and biochemical assays that CGRP induction by this
line is due to activin. This along with other work implicates
molecules that were not previously implicated in sensory
neuronal phenotypic choice as being involved in the devel-
opment of DRG neurons. Skin is only one target tissue for
CGRP-IR sensory neurons. Other potential target tissues
for CGRP sensory neurons such as gut will be similarly
assayed for active BMP-like molecules.
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